Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. - Wikidata - wikimedia - TriplyDB

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

http://www.wikidata.org/entity/Q33158687

about

Mast Cell Clonal Disorders: Classification, Diagnosis and Management Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes Mast Cell Activation Syndrome Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.Mast cell activation syndrome: a review.The presence of mast cell clonality in patients with unexplained anaphylaxis.Hymenoptera Allergy and Mast Cell Activation Syndromes.Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome Systemic mastocytosis in the elderly.Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics Identification of microRNAs regulating the developmental pathways of bone marrow derived mast cells.Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.Familial occurrence of systemic mast cell activation disease.Diagnosis and treatment of mast cell disorders: practical recommendations.Determination of plasma heparin level improves identification of systemic mast cell activation disease Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.Concomitant chronic pulmonary diseases and their association with hospital outcomes in patients with anaphylaxis and other allergic conditions: a cohort study.Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.Update on diagnosis and treatment of mastocytosis.Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis.Insect allergy.Current state of biology and diagnosis of clonal mast cell diseases in adults.Evaluation of mast cell activation syndromes: impact of pathology and immunohistology.Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.Immunology and clinical manifestations of non-clonal mast cell activation syndrome Anaphylaxis as a clinical manifestation of clonal mast cell disorders.Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.H1-antihistamines for primary mast cell activation syndromes: a systematic review.Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.Mast cell disorders in Ehlers-Danlos syndrome.Insights in Anaphylaxis and Clonal Mast Cell Disorders.Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM)Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.

P2860

Q28070386-0873835C-AE3C-4D8D-B252-ADB26493FE8C Q28078468-4A3C7A6C-F58B-498B-8586-E07EBCF0C401 Q28261609-70EE6306-FA6E-46F2-A630-6F0894854B0A Q33160609-DF38C4E1-6A39-46C6-A7CA-506941374CD5 Q33162066-A19E5394-F371-4E00-9EB9-D8F620F39D86 Q33164531-EB7EFBD8-0652-437F-B02C-5202EF85D4BD Q33166619-AB305A05-865D-49F9-9BEC-362CBE9C0C71 Q33168552-018B71CC-A411-4D16-B9F4-969BB71A34B0 Q33406056-C41FF34E-D3B6-4743-811D-11BC6DF0A738 Q33607136-14526540-E169-451B-A89E-81AB1CE3897E Q33646084-F2609425-E702-44D8-B1FB-F54AC3A207EB Q34663681-23B0663D-9746-4F34-A82D-43F6D1AF4926 Q34812525-E4D37600-77A9-44A3-8786-D86D721E1277 Q35010297-EFEA9EDD-72DB-4B89-9153-8F521323477A Q35021196-A7AFE416-F2F0-4215-B361-CE47881F553A Q35536695-6C455C4F-B4CA-4E6F-BA65-8C0CCB341A08 Q35574171-11DE12FE-E623-4544-B1DE-CC871875940A Q36992927-DF5582D9-6D3A-4A06-ABE7-B17440CA5F59 Q37065190-2525990E-505B-46FB-9B3F-452A2E09202F Q37729070-ED41B3B5-8839-48CF-8FDC-090E0577CCEB Q37854888-62C31CFE-4FD1-4F98-B968-995B0BA50A5D Q37869373-8B6812E6-EB3F-4757-AD55-30C498263654 Q37873485-AE35C9EE-6CA1-426A-BAB0-6B4626BBA78D Q37892475-3E418B79-E1C0-43C8-8777-8AEAF98B47C6 Q37931150-C82D0E83-C74A-44F9-BBC9-66D295CCF112 Q38007005-A810FBD8-5C07-46B4-B47A-B23CD4835413 Q38007288-E495D577-2C99-448A-9C52-495CE298684C Q38041575-02D3184B-5E1E-45EC-8CA5-1F2F4FAB04FD Q38065108-BB4E2E02-28BF-4141-B60C-2C2DAD9CAF55 Q38221739-38751DC8-049C-46C2-A76A-0123A3245799 Q38396594-70E1CDFD-845F-4CF6-A753-6BBC53E7E288 Q38504083-34EA242E-1CB1-4A56-B891-7A380932C0D2 Q38533582-66CAF861-E9A3-4FA8-BA74-F72A7F931393 Q38542316-37A400F5-CA7F-4817-8BAC-CC6672E06894 Q38543373-800E40F4-C9F2-4B32-9F60-B1F2682EB4A7 Q38582624-DE9131BC-C6A9-4D06-AD05-DA10709C36C5 Q39163000-36B27205-6F0E-4D9D-AB7C-6AD9E8F2E130 Q39455752-3A19E77E-AA63-4C01-BEBA-7616C29C3A1C Q40582535-521B75D3-48F6-4F52-8996-58331B86BCE1 Q40976858-D36D1C35-AA94-4243-AF7A-95F6BA672013

P2860

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

http://www.wikidata.org/entity/Q33158687

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical, biological, and mole ...... mast cell activation symptoms.

@ast

Clinical, biological, and mole ...... mast cell activation symptoms.

@en

type

label

Clinical, biological, and mole ...... mast cell activation symptoms.

@ast

Clinical, biological, and mole ...... mast cell activation symptoms.

@en

prefLabel

Clinical, biological, and mole ...... mast cell activation symptoms.

@ast

Clinical, biological, and mole ...... mast cell activation symptoms.

@en

P1433

Q33158687-716D097B-F1CC-4182-BE7B-053B322BD509

P1476

Q33158687-76AFD3A1-02AB-43E0-BB10-250F566A1D46

P2093

Q33158687-031D6553-43D7-465C-801B-A645D227D6EA

Q33158687-0ABB504F-052C-4319-9521-4D53364D98E1

Q33158687-392F8DB4-0773-45C4-90B3-A86C2233F5A6

Q33158687-54C22AFC-A3F6-4291-A72E-C97F23581B55

Q33158687-6629D4D0-21B3-425F-AD82-7CE626642378

Q33158687-6A3F392F-389C-49B4-A54E-724C69BCF915

Q33158687-782FD04B-8578-4661-AA30-6FBC74770E7D

Q33158687-C1AF57A0-CEBF-4938-BF9E-4D908F2C08AE

Q33158687-C5F43A41-1C8D-4265-9241-DD97DCC64317

Q33158687-CCE97938-322B-4BF8-9E49-C78BD68C1B9F

P304

Q33158687-2ACEFF1C-D948-4828-80DE-0F0740D8B752

P31

Q33158687-98221900-4562-49B7-97F5-4765AC9B8626

P356

Q33158687-018D4850-ECEC-40AC-95E7-CDDF7F4C9C14

P407

Q33158687-BC2CAD0D-CF2E-40C5-A2F7-835A88EEB90F

P433

Q33158687-8C346117-8891-4242-AD2B-AD3ED4E07DFB

P478

Q33158687-DC16440F-0A34-429F-869A-92AFED96AF2F

P50

Q33158687-163B2D0F-078B-4E28-ABC2-4F6175486DC4

Q33158687-168F961F-67E1-45DA-AE3D-69675DAD5D59

Q33158687-27106E03-2B5C-429F-A11E-9273A532E5CF

Q33158687-36C484FA-1701-4D04-B371-D990AE4B5D41

Q33158687-5AEF8665-5DFF-40D2-8D5B-75A02999F2DD

Q33158687-79251A4F-BD2B-42D8-8E53-018DC0FDC084

Q33158687-C950D98C-5C3D-4B0E-971C-F53E624594F5

P577

Q33158687-0F9C59AD-AFCC-476C-85D9-92476AE28CFD

P698

Q33158687-A8699772-B15B-473D-A28C-17EC4842F93C

P921

Q33158687-A802CC1D-B769-4C30-9B10-90F3DC6734D0

P356

J.JACI.2010.02.019

P1433

The Journal of Allergy and Clinical Immunology

P1476

Clinical, biological, and mole ...... mast cell activation symptoms

@en

P2093

Alberto Orfao

http://www.w3.org/2001/XMLSchema#string

Arantza Vega

http://www.w3.org/2001/XMLSchema#string

Belén de la Hoz

http://www.w3.org/2001/XMLSchema#string

Cristina Teodósio

http://www.w3.org/2001/XMLSchema#string

David González de Olano

http://www.w3.org/2001/XMLSchema#string

Isabel Sánchez Matas

http://www.w3.org/2001/XMLSchema#string

Luis Escribano

http://www.w3.org/2001/XMLSchema#string

Manuela Mollejo

http://www.w3.org/2001/XMLSchema#string

Maria Belén Mateo

http://www.w3.org/2001/XMLSchema#string

Maria D Alonso Díaz de Durana

http://www.w3.org/2001/XMLSchema#string

P304

1269-1278.e2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2010.02.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

María Jara-acevedo

Andrés García-Montero

Teresa Caballero

L Sanchez-Muñoz

Iván Alvarez-Twose

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20434205

http://www.w3.org/2001/XMLSchema#string

P921